Adjuvant Treatment of Gastric Cancer in the D2 Dissection Era: A Real-life Experience from a Multicenter Retrospective Cohort Study-Reference-Cited by-同舟云学术

Adjuvant Treatment of Gastric Cancer in the D2 Dissection Era: A Real-life Experience from a Multicenter Retrospective Cohort Study

Published:2021-10-22 Issue:2 Volume:11 Page:51-58
ISSN:2231-5047
Container-title:Euroasian Journal of Hepato-Gastroenterology
language:en
Short-container-title:

Author:

Yekedüz Emre,Doğan İzzet,Birgi Sümerya D,Keskin Metin,Karaman Şule,Utkan Güngör,Karabulut Senem,Bayar Sancar,Akbulut Hakan,Demirci Salim,Akyürek Serap,Ürün Yüksel

Publisher

Jaypee Brothers Medical Publishing

Link

https://www.ejohg.com/doi/pdf/10.5005/jp-journals-10018-1343

Reference12 articles.

1. 1. Smalley SR, Benedetti JK, Haller DG, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 2012;30(19):2327–2333. DOI: 10.1200/JCO.2011.36.7136.

2. 2. Lee J, Lim DH, Kim S, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol 2012;30(3):268–273. DOI: 10.1200/JCO.2011.39.1953.

3. 3. Park SH, Sohn TS, Lee J, et al. Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses. J Clin Oncol 2015;33(28):3130–3136. DOI: 10.1200/JCO.2014.58.3930.

4. 4. Cats A, Jansen EPM, van Grieken NCT, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol 2018;19(5):616–628. DOI: 10.1016/S1470-2045(18)30132-3.

5. 5. Park SH, Lim DH, Sohn TS, et al. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial. Ann Oncol 2021;32(3):368–374. DOI: 10.1016/j.annonc.2020.11.017.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients: A Systematic Review and Meta-Analysis;Annals of Surgical Oncology;2022-06-20